SEOM clinical guidelines for the treatment of head and neck cancer (2017).

Autor: Iglesias Docampo LC; Hospital Universitario 12 de Octubre, Madrid, Spain. laraiglesias@hotmail.com., Arrazubi Arrula V; Hospital de Basurto, Bilbao, Spain., Baste Rotllan N; Hospital Universitario Vall d´Hebrón, Barcelona, Spain., Carral Maseda A; Hospital Universitario Lucus Augusti, Lugo, Spain., Cirauqui Cirauqui B; Hospital Universitari Germans Trias i Pujol, Badalona, Spain., Escobar Y; Hospital General Universitario Gregorio Marañón, Madrid, Spain., Lambea Sorrosal JJ; Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain., Pastor Borgoñón M; Hospital Universitari I Politècnic la Fe, Valencia, Spain., Rueda A; Complejo Hospital Costa del Sol, Málaga, Marbella, Spain., Cruz Hernández JJ; Hospital Universitario de Salamanca, Salamanca, Spain.
Jazyk: angličtina
Zdroj: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2018 Jan; Vol. 20 (1), pp. 75-83. Date of Electronic Publication: 2017 Nov 20.
DOI: 10.1007/s12094-017-1776-1
Abstrakt: Head and neck cancer (HNC) is defined as malignant tumours located in the upper aerodigestive tract and represents 5% of oncologic cases in adults in Spain. More than 90% of these tumours have squamous histology. In an effort to incorporate evidence obtained since 2013 publication, Spanish Society of Medical Oncology (SEOM) presents an update of HNC diagnosis and treatment guideline. The eighth edition of TNM classification, published in January 2017, introduces important changes for p16-positive oropharyngeal tumours, for lip and oral cavity cancer and for N3 category. In addition, there are new data about induction chemotherapy and the role of immunotherapy in HNC.
Databáze: MEDLINE
Externí odkaz: